Zobrazeno 1 - 4
of 4
pro vyhledávání: '"S J Harnett"'
Publikováno v:
Journal of Antimicrobial Chemotherapy. 53:783-792
Objectives The in vitro activity of a new fluoroquinolone, ABT-492, was determined. Methods MICs were compared with those of two beta-lactams, telithromycin, ciprofloxacin and four later generation fluoroquinolones. The effects of human serum and of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffc9b12e2303d4468b1e5b027bdc387f
https://doi.org/10.1093/jac/dkh180
https://doi.org/10.1093/jac/dkh180
Autor:
Carmen L. Sheppard, Robert George, R. A. Walker, Michael Gill, Alan P. Johnson, S. J. Harnett, Andrew Birtles, N. P. Brenwald, David M. Livermore, Timothy G. Harrison
Publikováno v:
Journal of Antimicrobial Chemotherapy. 52:953-960
To determine the epidemiological relationship between pneumococci of serotype 9V, with reduced susceptibility to ciprofloxacin, penicillin and erythromycin, referred to the Reference Laboratory during 1997-2001.Isolates were characterized by multiloc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab342978d4394830d808195225eb7216
https://doi.org/10.1093/jac/dkg469
https://doi.org/10.1093/jac/dkg469
Publikováno v:
Journal of Antimicrobial Chemotherapy (JAC); Vol. 53 Issue 5, p783-792, 10p
Autor:
A. P. Johnson, C. L. Sheppard, S. J. Harnett, A. Birtles, T. Harrison, N. P. Brenwald, M. J. Gill, R. A. Walker, D. M. Livermore, R. C. George
Publikováno v:
Journal of Antimicrobial Chemotherapy (JAC); Dec2003, Vol. 52 Issue 6, p953-960, 8p